Table 2.
Treatment characteristics for LDRB
| Characteristics | Median (range) |
|---|---|
| No. of needles | 21 (17-24) |
| No. of sources | 57 (40-76) |
| Prostate volume, mL | 40.7 (25-48) |
| Source activity, mCi | 0.59 (0.4-0.6) |
| Preplanning/intraoperative prostate D90, Gy∗ | 176.8 (159.5-198.7) |
| Preplanning/intraoperative prostate V100† | 99% (96.7%-100%) |
| Preplanning/intraoperative prostate V150 | 62.6% (44.6%-77.5%) |
| Preplanning/intraoperative prostate V200 | 28.9% (18.6%-44.7%) |
| Preplanning/intraoperative urethra D5 | 91.5% (84.4%-110%) |
| Preplanning/intraoperative urethra V150, mL | 0 (0-17.5) |
| Prostate D90 on day 30 postimplant CT, Gy | 160.5 (138-190) |
| Rectum V100 on day 30 postimplant CT, mL | 0.2 (0-0.3) |
Abbreviations: CT = computed tomography; LDRB = low-dose-rate brachytherapy.
D90: Radiation dose delivered to 90% of the prostate volume.
V100: Volume of the prostate receiving 100% of the prescription dose.